Catalyst Pharmaceuticals Inc (CPRX)
25.72
-0.02
(-0.10%)
USD |
NASDAQ |
Mar 25, 16:00
25.72
0.00 (0.00%)
After-Hours: 19:46
Catalyst Pharmaceuticals Price to Book Value: 4.292 for March 25, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 9.049 |
| Halozyme Therapeutics Inc | 21.96 |
| Ionis Pharmaceuticals Inc | 8.727 |
| ADMA Biologics Inc | 13.79 |
| BridgeBio Pharma Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 19.63 |
| PS Ratio | 6.533 |
| PEG Ratio | 0.1710 |
| Price to Free Cash Flow | 13.43 |
| Price | 25.72 |
| Earnings Yield | 5.09% |
| Market Cap | 3.123B |
| PEGY Ratio | 0.1710 |
| Operating PE Ratio | 16.46 |
| Normalized PE Ratio | 20.21 |